8,952
Total Claims
$1.9M
Drug Cost
1,364
Beneficiaries
$1,359
Cost/Patient
Peer Comparison vs. 4,479 Interventional Cardiology providers
+29%
Cost per patient vs peers
$1,359 vs $1,054 avg
+30%
Brand preference vs peers
17.1% vs 13.1% avg
Brand vs Generic
83% generic
Brand: 1,532 claims · $1.7M
Generic: 7,420 claims · $203K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 504 | $730K |
| Ticagrelor | 224 | $252K |
| Evolocumab | 245 | $200K |
| Rivaroxaban | 120 | $158K |
| Sacubitril/Valsartan | 94 | $150K |
| Alirocumab | 158 | $106K |
| Metoprolol Succinate | 1,034 | $22K |
| Empagliflozin | 15 | $20K |
| Nebivolol Hcl | 68 | $14K |
| Clopidogrel Bisulfate | 785 | $14K |
| Tadalafil | 11 | $14K |
| Atorvastatin Calcium | 654 | $11K |
| Isosorbide Mononitrate | 490 | $11K |
| Ranolazine | 60 | $9,046 |
| Losartan Potassium | 520 | $8,292 |
Prescribing Profile
59
Unique Drugs
$1.1M
Patient Profile
76
Avg Age
48%
Female
1.38
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About